BIPHOZYL

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, Poland, Romania, Singapore, Turkey

Active ingredients

The drug BIPHOZYL contains a combination of these active pharmaceutical ingredients (APIs):

1 Magnesium chloride hexahydrate UNII 02F3473H9O - MAGNESIUM CHLORIDE

Read about Magnesium chloride

2 Sodium chloride UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. Read about Sodium chloride

3 Sodium hydrogen carbonate UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. Read about Sodium bicarbonate

4 Potassium chloride UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. Read about Potassium chloride

5 Disodium phosphate dihydrate UNII 94255I6E2T - SODIUM PHOSPHATE, DIBASIC, DIHYDRATE

Read about Sodium phosphate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BIPHOZYL Solution for haemodialysis	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05ZB	Hemofiltrates	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 503220110030807
Country: EE	Ravimiamet	Identifier(s): 1625891
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 79998
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 039918
Country: FR	Base de données publique des médicaments	Identifier(s): 65428529
Country: HK	Department of Health Drug Office	Identifier(s): 65328
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-197145098
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071196
Country: MT	Medicines Authority	Identifier(s): MA1277/03201
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100329553
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67896001, W67896002
Country: SG	Health Sciences Authority	Identifier(s): 15514P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681413881459, 8681413881480